Did any named executive officers exercise options or have other stock awards vest in 2021?
All our named executive officers had outstanding awards of restricted stock units vest in 2021. No restricted stock or stock options vested in 2021. No options were exercised in 2021.
OPTION EXERCISES AND STOCK VESTED IN 2021(1)
| | Robert J. Sprowls | | | 25,086(3) | | | $1,398,367 | |
| | Eva G. Tang | | | 3,739(4) | | | 152,026 | |
| | Paul J. Rowley | | | 1,333 | | | 109,063 | |
| | Gladys M. Farrow | | | 2,872(5) | | | 120,438 | |
| | Bryan K. Switzer | | | 2,502(6) | | | 109,063 | |
| | Denise L. Kruger | | | 3,483(7) | | | 152,026 | |
(1) - We determined the value realized on vesting of restricted stock units based on the closing market price of our common shares on the date of vesting as reported on The Wall Street Journal website (www.wsj.com).
(2) - Includes performance stock award granted in 2019 which vested in 2021.
(3) - Out of 25,086 shares fully vested in 2021, Mr. Sprowls acquired 4,167 common shares on February 5, 2021, upon the payout of restricted stock units with a market value of $332,518 on the date of acquisition. Mr. Sprowls is entitled to acquire the remaining 20,919 common shares, which were not payable during 2021, because of the immediate vesting of these common shares under the Rule of 75. Mr. Sprowls acquired 4,098 of these common shares on February 4, 2022 with a market value of $367,520 on the date of acquisition. On March 14, 2022, Mr. Sprowls acquired 12,705 of these common shares (including 55 common shares with respect to dividends declared on February 1, 2022 pursuant to dividend equivalent rights on these shares) with an aggregate market value of $1,065,849 on the date of acquisition. Mr. Sprowls was entitled to acquire the remaining 4,116 common shares, which were not payable during 2021, because of the vesting of these common shares under the Rule of 75. Mr. Sprowls has the right to acquire 1,221 of these common shares within 30 days from January 27, 2023, 1,426 of these common shares within 30 days from January 31, 2023 and 1,469 of these common shares within 30 days from January 31, 2024 as a result of the previous vesting of the 4,116 restricted stock units, the value of which was not realized during 2021, plus common shares with respect to dividends declared after December 31, 2021 on these common shares pursuant to dividend equivalent rights on these shares until the date of acquisition of these shares.
(4) - Out of 3,739 shares fully vested in 2021, Ms. Tang acquired 934 common shares on February 5, 2021, upon the payout of restricted stock units with a market value of $74,531 on the date of acquisition. Ms. Tang is entitled to acquire the remaining 2,805 common shares, which were not payable during 2021, because of the immediate vesting of these common shares under the Rule of 75. Ms. Tang acquired 920 of these common shares on February 4, 2022 with a market value of $82,491 on the date of acquisition. On March 14, 2022, Ms. Tang acquired 924 of these common shares (including 4 common shares with respect to dividends declared on February 1, 2021 pursuant to dividend equivalent rights on these shares) with an aggregate market value of $77,495 on the date of acquisition. Ms. Tang was entitled to acquire the remaining 961 common shares, which were not payable during 2021, because of the vesting of these common shares under the Rule of 75. Ms. Tang has the right to acquire 254 of these common shares within 30 days from January 27, 2023, 349 of these common shares within 30 days from January 31, 2023 and 358 of these common shares within 30 days from January 31, 2024 as a result of the previous vesting of the 961 restricted stock units, the value of which was not realized during 2021, plus common shares with respect to dividends declared after December 31, 2021 on these common shares pursuant to dividend equivalent rights on these shares until the date of acquisition of these shares.
(5) - Out of 2,872 shares fully vested in 2021, Ms. Farrow acquired 670 common shares on February 5, 2021, upon the payout of restricted stock units with a market value of $53,482 on the date of acquisition. Ms. Farrow acquired 71 common shares on March 11, 2021, upon the payout of restricted stock units with a market value of $5,120 on the date of acquisition. Ms. Farrow is entitled to acquire the remaining 2,131 common shares, which were not payable during 2021, because of the immediate vesting of these common shares under the Rule of 75. Ms. Farrow acquired 674 of these common shares on February 4, 2022 with a market value of $60,476 on the date of acquisition. On March 14, 2022, Ms. Farrow acquired 737 of these common shares (including 3 common shares with respect to dividends declared on February 1, 2022 pursuant to dividend equivalent rights on these shares) with an aggregate market value of $61,836 on the date of acquisition. Ms. Farrow was entitled to acquire the remaining 720 common shares, which were not payable during 2021, because of the vesting of these common shares under the Rule of 75. Ms. Farrow has the right to acquire 183 of these common shares within 30 days from January 27, 2023, 264 of these common shares within 30 days from January 31, 2023 and 273 of
